510(k) K081674
K081674 is an FDA 510(k) premarket notification submitted by The Binding Site, Ltd. for the device "BINDAZYME HUMAN ANTI-GLIADIN (MGP), IGG EIA KIT; BINDAZYME HUMAN ANTI-GLIADIN (MGP) IGA EIA KIT; (IGA OR IGG)". The FDA issued a decision of Substantially Equivalent on Oct 15, 2008. The device falls under product code MST (Antibodies, Gliadin), a Class II device regulated under 21 CFR 866.5750. The Binding Site, Ltd. has 124 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 15, 2008
- Date Received
- Jun 17, 2008
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antibodies, Gliadin
- Device Class
- Class II
- Regulation Number
- 866.5750
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for The Binding Site, Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.